Discontinuation report STATEX SUPPOSITORIES 30MG
| Report ID | 152444 |
| Drug Identification Number | 00639389 |
| Brand name | STATEX SUPPOSITORIES 30MG |
| Common or Proper name | Statex 30mg suppositories |
| Company Name | PALADIN PHARMA INC. |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | MORPHINE SULFATE |
| Strength(s) | 30MG |
| Dosage form(s) | SUPPOSITORY |
| Route of administration | RECTAL RECTAL |
| Packaging size | 10 |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2022-01-10 |
| Remaining supply date | 2022-01-10 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 100 BLVD ALEXIS-NIHON, SUITE 600 MONTREAL, QUEBEC CANADA H4M 2P2 |
| Company contact information | 1-866-340-1112 paladincs@endo.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2022-01-10 | English | Compare |
| v2 | 2022-01-10 | French | Compare |
| v3 | 2022-01-11 | English | Compare |
Showing 1 to 3 of 3